[A new milestone in human embryo editing].
Medecine sciences : M/S, 33(5): 549-554 PMID 28612733 DOI 10.1051/medsci/20173305021
Abstract
Viable human embryos carrying a disease mutation have now been corrected by CRISPR-Cas9 editing. Although the correction is not perfect, and the embryos have not been implanted, this brings us closer to human germline editing and to the associated ethical questions.